{"id":"https://openalex.org/W7221932082","doi":"https://doi.org/10.3389/frhs.2026.1911647","title":"Pharmacological treatment, adversities, and mobile-based post-discharge follow-up of mucormycosis survivors in Central India: strengthening patient care","display_name":"Pharmacological treatment, adversities, and mobile-based post-discharge follow-up of mucormycosis survivors in Central India: strengthening patient care","publication_year":2026,"publication_date":"2026-10-15","ids":{"openalex":"https://openalex.org/W7221932082","doi":"https://doi.org/10.3389/frhs.2026.1911647","pmid":"https://pubmed.ncbi.nlm.nih.gov/42959169","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13716765"},"language":"en","primary_location":{"id":"doi:10.3389/frhs.2026.1911647","doi":"https://doi.org/10.3389/frhs.2026.1911647","is_oa":true,"landing_page_url":"https://doi.org/10.3389/frhs.2026.1911647","pdf_url":"https://www.frontiersin.org/journals/health-services/articles/10.3389/frhs.2026.1911647/pdf","source":{"id":"https://openalex.org/S4386621993","display_name":"Frontiers in Health Services","issn_l":"2813-0146","issn":["2813-0146"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Health Services","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/health-services/articles/10.3389/frhs.2026.1911647/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018845559","display_name":"Ruchi Baghel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3130004915","display_name":"Ruxmaniben Deepchand Gardi Medical College","ror":"https://ror.org/01cv9mb69","country_code":"IN","type":"education","lineage":["https://openalex.org/I3130004915"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ruchi Baghel","raw_affiliation_strings":["Department of Pharmacology, R. D. Gardi Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, R. D. Gardi Medical College","institution_ids":["https://openalex.org/I3130004915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109124561","display_name":"Preeti Acharya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3130004915","display_name":"Ruxmaniben Deepchand Gardi Medical College","ror":"https://ror.org/01cv9mb69","country_code":"IN","type":"education","lineage":["https://openalex.org/I3130004915"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Preeti Acharya","raw_affiliation_strings":["Department of Pharmacology, R. D. Gardi Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, R. D. Gardi Medical College","institution_ids":["https://openalex.org/I3130004915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158784830","display_name":"Anshu Verma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anshu Verma","raw_affiliation_strings":["Department of Otorhinolaryngology, Government District Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Otorhinolaryngology, Government District Hospital","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5158833494","display_name":"Megha Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I3130004915","display_name":"Ruxmaniben Deepchand Gardi Medical College","ror":"https://ror.org/01cv9mb69","country_code":"IN","type":"education","lineage":["https://openalex.org/I3130004915"]}],"countries":["IN","SE"],"is_corresponding":true,"raw_author_name":"Megha Sharma","raw_affiliation_strings":["Department of Global Public Health, Health Systems and Policy, Medicines (focusing antibiotics), Karolinska Institutet","Department of Pharmacology, R. D. Gardi Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Public Health, Health Systems and Policy, Medicines (focusing antibiotics), Karolinska Institutet","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Department of Pharmacology, R. D. Gardi Medical College","institution_ids":["https://openalex.org/I3130004915"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5158833494"],"corresponding_institution_ids":["https://openalex.org/I28166907","https://openalex.org/I3130004915"],"apc_list":{"value":2550,"currency":"CHF","value_usd":3077},"apc_paid":{"value":2550,"currency":"CHF","value_usd":3077},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.7886518,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"1911647","last_page":"1911647"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mucormycosis","display_name":"mucormycosis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/rhinocerebral-mucormycosis","display_name":"rhinocerebral mucormycosis","score":0.9599999785423279},{"id":"https://openalex.org/keywords/post-acute-sequelae-of-covid-19","display_name":"post-COVID-19 sequelae","score":0.8769999742507935},{"id":"https://openalex.org/keywords/post-discharge-follow-up","display_name":"post-discharge follow-up","score":0.765999972820282},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7409999966621399},{"id":"https://openalex.org/keywords/liposomal-amphotericin-b","display_name":"liposomal amphotericin B","score":0.968999981880188},{"id":"https://openalex.org/keywords/posaconazole","display_name":"posaconazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antifungal-therapy","display_name":"antifungal therapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8690000176429749},{"id":"https://openalex.org/keywords/corticosteroid-exposure","display_name":"corticosteroid exposure","score":0.8009999990463257},{"id":"https://openalex.org/keywords/treatment-non-response","display_name":"treatment non-response","score":0.6389999985694885},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.7940000295639038},{"id":"https://openalex.org/keywords/central-india","display_name":"Central India","score":0.574999988079071},{"id":"https://openalex.org/keywords/long-term-survivorship","display_name":"long-term survivorship","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9067000150680542},{"id":"https://openalex.org/C2777292849","wikidata":"https://www.wikidata.org/wiki/Q6931254","display_name":"Mucormycosis","level":2,"score":0.7523999810218811},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.6323999762535095},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.60589998960495},{"id":"https://openalex.org/C2778566413","wikidata":"https://www.wikidata.org/wiki/Q906453","display_name":"Posaconazole","level":4,"score":0.5533999800682068},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.492900013923645},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.47749999165534973},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.47530001401901245},{"id":"https://openalex.org/C2777238321","wikidata":"https://www.wikidata.org/wiki/Q876887","display_name":"Cellulitis","level":2,"score":0.43459999561309814},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.42500001192092896},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4097999930381775},{"id":"https://openalex.org/C2776743756","wikidata":"https://www.wikidata.org/wiki/Q5097921","display_name":"Safeguarding","level":2,"score":0.38850000500679016},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3815000057220459},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3625999987125397},{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.3107999861240387},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30219998955726624},{"id":"https://openalex.org/C3018838755","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Medical care","level":2,"score":0.2971000075340271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2957000136375427},{"id":"https://openalex.org/C206179267","wikidata":"https://www.wikidata.org/wiki/Q188952","display_name":"Medical history","level":2,"score":0.29100000858306885},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.27239999175071716},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.267300009727478},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.257099986076355},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2556999921798706},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25099998712539673}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/frhs.2026.1911647","doi":"https://doi.org/10.3389/frhs.2026.1911647","is_oa":true,"landing_page_url":"https://doi.org/10.3389/frhs.2026.1911647","pdf_url":"https://www.frontiersin.org/journals/health-services/articles/10.3389/frhs.2026.1911647/pdf","source":{"id":"https://openalex.org/S4386621993","display_name":"Frontiers in Health Services","issn_l":"2813-0146","issn":["2813-0146"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Health Services","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13716765","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716765/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716765/pdf/frhs-06-1911647.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Health Serv","raw_type":"Text"},{"id":"pmid:42959169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42959169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in health services","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:dfc1b69fa9c145e7ae8d1373986778b0","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/dfc1b69fa9c145e7ae8d1373986778b0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Health Services, Vol 6 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/frhs.2026.1911647","doi":"https://doi.org/10.3389/frhs.2026.1911647","is_oa":true,"landing_page_url":"https://doi.org/10.3389/frhs.2026.1911647","pdf_url":"https://www.frontiersin.org/journals/health-services/articles/10.3389/frhs.2026.1911647/pdf","source":{"id":"https://openalex.org/S4386621993","display_name":"Frontiers in Health Services","issn_l":"2813-0146","issn":["2813-0146"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Health Services","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221932082.pdf","grobid_xml":"https://content.openalex.org/works/W7221932082.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1765287762","https://openalex.org/W2134541747","https://openalex.org/W2138399709","https://openalex.org/W2161467702","https://openalex.org/W2275737843","https://openalex.org/W2336677740","https://openalex.org/W2780214698","https://openalex.org/W2791487059","https://openalex.org/W2795684157","https://openalex.org/W2887257799","https://openalex.org/W2972332343","https://openalex.org/W2987248752","https://openalex.org/W2993195785","https://openalex.org/W3008028633","https://openalex.org/W3018023298","https://openalex.org/W3086502965","https://openalex.org/W3096253920","https://openalex.org/W3134134106","https://openalex.org/W3153696101","https://openalex.org/W3166420836","https://openalex.org/W3172102251","https://openalex.org/W3176054457","https://openalex.org/W3194803702","https://openalex.org/W3202325755","https://openalex.org/W3208067742","https://openalex.org/W3213218790","https://openalex.org/W3213612899","https://openalex.org/W4210475015","https://openalex.org/W4214591971","https://openalex.org/W4214944044","https://openalex.org/W4284885268","https://openalex.org/W4295778222","https://openalex.org/W4305057925","https://openalex.org/W4311472757","https://openalex.org/W4361215264","https://openalex.org/W4379741127","https://openalex.org/W4391447278","https://openalex.org/W4391932699","https://openalex.org/W4396624556","https://openalex.org/W4400857383","https://openalex.org/W4401857247","https://openalex.org/W4404459588","https://openalex.org/W4406090633","https://openalex.org/W4410280613","https://openalex.org/W4411227393","https://openalex.org/W4412776734","https://openalex.org/W7124764658"],"related_works":["https://openalex.org/W4306290780","https://openalex.org/W4285309809","https://openalex.org/W4396531240","https://openalex.org/W4412048253","https://openalex.org/W4323522246","https://openalex.org/W4400789294","https://openalex.org/W4386724693","https://openalex.org/W4306158115","https://openalex.org/W4206861826","https://openalex.org/W3185330418"],"abstract_inverted_index":{"Introduction":[0],"Mucormycosis,":[1],"a":[2,34,242,291],"significant":[3],"post-COVID-19":[4],"complication,":[5],"is":[6,27],"stimulated":[7],"by":[8,218],"uncontrolled":[9],"diabetes":[10],"mellitus":[11],"(DM),":[12],"prolonged":[13],"corticosteroid":[14],"exposure,":[15],"or":[16],"immunosuppression.":[17],"Despite":[18],"clinical":[19,69,115],"advancements,":[20],"survivors":[21,96,314],"experience":[22],"long-term":[23,40],"challenges;":[24],"however,":[25],"follow-up":[26,71,248,297],"often":[28],"missing":[29],"from":[30,90],"treatment":[31],"strategies,":[32],"highlighting":[33,272],"critical":[35],"gap":[36],"in":[37,85,100,142,197,318],"safeguarding":[38],"survivors\u2019":[39],"well-being.":[41],"Objective":[42],"To":[43],"analyze":[44],"pharmacological":[45],"management,":[46],"adverse":[47,173],"events,":[48],"and":[49,61,70,93,112,117,150,160,191,250,259,301,309,330],"post-discharge":[50,110,206,328],"outcomes":[51],"among":[52,178],"rhino-orbital":[53],"cerebral":[54],"mucormycosis":[55,137],"(ROCM)":[56],"patients":[57],"using":[58,102,129],"medical":[59,91],"records":[60,92],"Mobile-Based":[62],"Post-Discharge":[63],"(MBPD)":[64],"follow-up,":[65],"to":[66,106,195,326],"inform":[67],"future":[68],"practices.":[72],"Method":[73],"Clinical":[74],"data":[75],"of":[76,144,171,201,290,313,315],"confirmed":[77,217],"ROCM":[78],"inpatients":[79],"(2021)":[80],"at":[81],"two":[82],"COVID-19-dedicated":[83],"hospitals":[84],"Central":[86],"India":[87],"were":[88,97,120,127,153,166,176,185,261,280],"extracted":[89],"analyzed.":[94],"Mucormycosis":[95],"followed":[98],"up":[99],"2023":[101],"the":[103,247,262,268,273,286,311,319],"MBPD":[104,198,296],"questionnaire":[105],"explore":[107],"overall":[108],"treatment,":[109],"adversities,":[111,207,284],"outcomes.":[113],"The":[114,295],"findings":[116],"patient-reported":[118],"experiences":[119],"summarised":[121],"descriptively.":[122],"Factors":[123],"associated":[124,225,282],"with":[125,226,283],"adversities":[126,210,227],"examined":[128],"multivariable":[130],"Firth-penalized":[131],"logistic":[132],"regression.":[133],"Results":[134],"Among":[135],"108":[136],"patients,":[138],"DM":[139,266],"was":[140,223,267,298],"present":[141],"32%":[143],"inpatients.":[145,180],"Liposomal":[146,255],"amphotericin":[147,256],"B":[148],"(71%)":[149],"posaconazole":[151],"(75%)":[152],"predominantly":[154],"prescribed.":[155,168],"Access":[156],"(40%),":[157],"Watch":[158],"(39%),":[159],"Not":[161],"Recommended":[162],"antibiotic":[163],"combinations":[164],"(13%)":[165],"most":[167,263,269],"An":[169],"average":[170],"1.3":[172],"drug":[174],"reactions":[175],"recorded":[177],"73":[179],"Of":[181],"97":[182],"survivors,":[183],"36":[184],"non-responders.":[186],"Eighty":[187],"could":[188],"be":[189],"contacted,":[190],"61":[192,202],"(76%)":[193],"consented":[194],"participate":[196],"follow-up.":[199],"Fifty-two":[200],"respondents":[203],"reported":[204],"123":[205],"averaging":[208],"2.4":[209],"per":[211],"patient,":[212],"including":[213],"9":[214],"(7%)":[215],"deaths":[216],"family":[219],"members.":[220],"Antifungal":[221,278],"prescription":[222],"significantly":[224,281],"(aOR":[228],"5.82,":[229],"95%":[230],"CI":[231],"1.56\u221221.71;":[232],"p":[233],"=":[234],"0.009),":[235],"whereas":[236],"older":[237],"age":[238],"(>60":[239],"years)":[240],"showed":[241],"borderline":[243],"association.":[244],"Respondents":[245],"appreciated":[246],"calls":[249],"emphasized":[251],"regularizing":[252],"them.":[253],"Conclusion":[254],"B,":[257],"posaconazole,":[258],"antibiotics":[260],"prescribed":[264],"drugs.":[265],"common":[270],"comorbidity,":[271],"need":[274,287],"for":[275,288],"careful":[276],"monitoring.":[277],"prescriptions":[279],"suggesting":[285],"implementation":[289],"contextual":[292],"drug-use":[293],"policy.":[294],"well":[299],"received":[300],"may":[302],"help":[303],"monitor":[304],"recovery,":[305],"identify":[306],"health":[307],"needs,":[308],"support":[310,327],"care":[312,322],"chronic":[316],"diseases":[317],"future.":[320],"Survivor-centred":[321],"models":[323],"are":[324],"suggested":[325],"recovery":[329],"multidimensional":[331],"challenges.":[332]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2026-10-16T00:00:00"}